← Insider buys
RETA

Reata Pharmaceuticals Inc

Chief Research Officer Colin John Meyer sold $4.2M of Reata Pharmaceuticals Inc

Sold$4,239,148
$169.57Price
25,000Shares
−26%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Mon, Nov 16. Filed Wed, Nov 18, 11:19 AM ET, during the session. Not investment advice.